Inventor · disambiguated record
Timothy Norris
Also filed as: NORRIS TIMOTHY
18 granted patents·2 pending applications·345 citations·filing 1994–2005
94Inventor score
Top patents by PatentIndex Score
20 records- 0194US6900221B1Stable polymorph on N-(3-ethynylphenyl)-6, 7-bis (2methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereofOSI PHARM INC·Filed 2000·Granted May 31, 2005·100 cites·79 claims
- 0293US6476040B1Processes and intermediates for preparing anti-cancer compoundsPFIZER·Filed 2000·Granted Nov 5, 2002·106 cites·17 claims
- 0391US7087613B2Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochlorideOSI PHARM INC·Filed 2004·Granted Aug 8, 2006·47 cites·14 claims
- 0476US6262067B1Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositionsPFIZER·Filed 2000·Granted Jul 17, 2001·17 cites·21 claims
- 0573US6706721B1N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrateOSI PHARM INC·Filed 1999·Granted Mar 16, 2004·13 cites·12 claims
- 0670US7521456B2N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrateOSI PHARM INC·Filed 2003·Granted Apr 21, 2009·3 cites·13 claims
- 0769US6159976APolymorph of zopolrestat monohydratePFIZER·Filed 1999·Granted Dec 12, 2000·28 cites·26 claims
- 0865US6239285B1Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systemsPFIZER·Filed 2000·Granted May 29, 2001·4 cites·1 claims
- 0960US6344563B1Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systemsFiled 2000·Granted Feb 5, 2002·2 cites·7 claims
- 1058US6346624B1Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systemsPFIZER·Filed 2000·Granted Feb 12, 2002·1 cites·2 claims
- 1147US7019009B2Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activityPFIZER·Filed 2003·Granted Mar 28, 2006·0 cites·27 claims
- 1246US6753334B2Preparation of sodium-hydrogen exchanger type-1 inhibitorsPFIZER·Filed 2001·Granted Jun 22, 2004·0 cites·12 claims
- 1346US5763454ACrystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid saltPFIZER·Filed 1995·Granted Jun 9, 1998·11 cites·4 claims
- 1444US6114531AProcess for preparing quinolone and naphthyridone carboxylic acidsPFIZER·Filed 1999·Granted Sep 5, 2000·2 cites·6 claims
- 1543US5929240AProcess and intermediates for preparing naphthyridonecarboxylic acid saltsPFIZER·Filed 1994·Granted Jul 27, 1999·2 cites·33 claims
- 1638US2007208172A1Process for Preparing Cephalosporin Intermediates Using Alpha-Iodo-1-Azetidineacetic Acid Esters and TrialkylphosphitesPFIZER·Filed 2005·Application pending·0 cites
- 1736US6066647AZwitterionic forms of trovafloxacinPFIZER·Filed 1996·Granted May 23, 2000·8 cites·8 claims
- 1834US6080756APolymorphs of the prodrug 6-N-(L-ALA-L-ALA)-trovafloxacinPFIZER·Filed 1996·Granted Jun 27, 2000·1 cites·10 claims
- 1930US6359137B1Process for preparing trovafloxacin acid saltsPFIZER·Filed 1999·Granted Mar 19, 2002·0 cites·21 claims
- 2027US2002147218A1Ethanolates of sodium-hydrogen exchanger type-1 inhibitorFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Timothy Norris files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →